We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
(-8.5%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-11.98%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$11.2M |
| 2 |
ExxonMobil
XOM
|
+$10.8M |
| 3 |
Apple
AAPL
|
+$10.8M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$10.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$8.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$265M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$98.3M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$32.7M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$18.2M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$14.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 8.29% |
| 3 | Industrials | 7.33% |
| 4 | Healthcare | 6.94% |
| 5 | Consumer Discretionary | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
1951
DELISTED
Acceleron Pharma
XLRN
| $25K | ﹤0.01% |
993
+129
| +15% | +$4.09K |
|
|
ORBK
1952
DELISTED
Orbotech Ltd
ORBK
| $25K | ﹤0.01% |
741
+251
| +51% | +$7.67K |
|
|
ILG
1953
DELISTED
ILG, Inc Common Stock
ILG
| $25K | ﹤0.01% |
+1,393
| New | +$24.4K |
|
|
CDI
1954
DELISTED
CDI Corp.
CDI
| $25K | ﹤0.01% |
+3,440
| New | +$23.6K |
|
|
SPNC
1955
DELISTED
Spectranetics Corp
SPNC
| $25K | ﹤0.01% |
+1,004
| New | +$23.6K |
|
|
XCO
1956
DELISTED
Exco Resources
XCO
| $25K | ﹤0.01% |
+1,926
| New | +$30.9K |
|
|
SBY
1957
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $25K | ﹤0.01% |
1,463
+1,263
| +632% | +$21.7K |
|
|
LOCK
1958
DELISTED
LifeLock, Inc.
LOCK
| $25K | ﹤0.01% |
+1,036
| New | +$21.1K |
|
|
DCM
1959
DELISTED
NTT DOCOMO, Inc.
DCM
| $25K | ﹤0.01% |
+1,084
| New | +$25.6K |
|
|
DDC
1960
DELISTED
Dominion Diamond Corporation
DDC
| $25K | ﹤0.01% |
2,600
-7,056
| -73% | -$64.4K |
|
1961
American Coastal Insurance
ACIC
$494M
| $24K | ﹤0.01% |
+1,607
| New | +$23K |
|
1962
Alerian MLP ETF
AMLP
$12.8B
| $24K | ﹤0.01% |
+381
| New | +$23.5K |
|
1963
AB InBev
BUD
$165B
| $24K | ﹤0.01% |
223
-1,189
| -84% | -$133K |
|
|
CLSD
1964
DELISTED
Clearside Biomedical
CLSD
| $24K | ﹤0.01% |
179
-442
| -71% | -$111K |
|
1965
Crawford & Co Class B
CRD.B
$604M
| $24K | ﹤0.01% |
+1,901
| New | +$23.5K |
|
1966
Eldorado Gold
EGO
$9.89B
| $24K | ﹤0.01% |
1,503
-16,536
| -92% | -$260K |
|
|
GAU
1967
Galiano Gold
GAU
$538M
| $24K | ﹤0.01% |
7,832
-3,944
| -33% | -$13.6K |
|
1968
Graco
GGG
$13.5B
| $24K | ﹤0.01% |
873
-6,012
| -87% | -$158K |
|
1969
Graphic Packaging
GPK
$3.58B
| $24K | ﹤0.01% |
1,942
-6,436
| -77% | -$83.2K |
|
1970
Guidewire Software
GWRE
$14.2B
| $24K | ﹤0.01% |
496
+365
| +279% | +$20.5K |
|
1971
MarineMax
HZO
$788M
| $24K | ﹤0.01% |
+1,234
| New | +$23.8K |
|
1972
ICU Medical
ICUI
$4.61B
| $24K | ﹤0.01% |
+161
| New | +$23.3K |
|
1973
iShares Core 10+ Year USD Bond ETF
ILTB
$596M
| $24K | ﹤0.01% |
+392
| New | +$24.4K |
|
1974
Kosmos Energy
KOS
$1.48B
| $24K | ﹤0.01% |
3,370
-4,496
| -57% | -$25.6K |
|
1975
Lee Enterprises
LEE
$182M
| $24K | ﹤0.01% |
+822
| New | +$24.6K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review
As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.
Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.
- Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
- Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
- Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
- Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
- Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
- Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.